Navigation Links
Human Genome Sciences Names Kevin P. McRaith Vice President, Hepatology Franchise
Date:5/15/2008

ROCKVILLE, Md., May 15 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced that Kevin P. McRaith has joined the Company as Vice President, Hepatology Franchise. Mr. McRaith, formerly Vice President, Sales & Marketing - Hematology, Genentech Corporation, will report to Barry A. Labinger, Executive Vice President and Chief Commercial Officer.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080416/HGSLOGO )

"Kevin McRaith brings to HGS a wealth of experience and an established record of accomplishment in the successful commercialization of products in a number of therapeutic areas," said Mr. Labinger. "I am excited to have Kevin join our senior management team to play a key role in our efforts to build a world class commercial organization. As head of our Hepatology Franchise, Kevin will have responsibility for all marketing and sales activities for Albuferon, including leading our preparation for launch and managing the overall performance of our Albuferon business."

Mr. McRaith has more than 20 years of experience commercializing therapies for infectious diseases, oncology, neurological diseases and cardiology. As Vice President, Sales and Marketing for Genentech's Hematology Franchise, he led the commercial efforts for the top-selling biologic, Rituxan (rituximab). Prior to joining Genentech in 2005, Mr. McRaith served with Abbott Laboratories for 15 years, where he held a number of senior positions with responsibility for managing major product franchises, directing marketing and sales activities, and leading a number of successful launches. Before joining Abbott in 1990, he spent several years in sales and
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Volcano Corp Announces First Human Use of the Volcano Optical Coherence Tomography (OCT) Imaging Catheter
2. Human Genome Sciences Announces First Quarter 2008 Financial Results and Key Developments
3. Pioneer(R) Surgical Technology Announces First Human Implants of its NuNec(TM) Cervical Arthroplasty Device
4. China Biologic Products Announces SFDA Approval for the Production of Cryoprecipitate and for the Clinical Trial of Human Prothrombin Complex
5. Human Genome Sciences to Sponsor Conference Call to Discuss First Quarter 2008 Financial Results
6. Identity Sciences Introduces a New, Fast Forensic Human I.D. Test
7. Human Genome Sciences Advances Oncology Portfolio
8. AMDL Signs Exclusive Licensing Agreement for Human Papilloma Virus Diagnostic Test Kit in Certain Asian Countries
9. Human Pheromone Sciences Announces Quarterly and Full Year Results
10. CryoLife Announces Implant of First FDA-Cleared SynerGraft(R) Processed Human Pulmonary Heart Valve
11. Oregon Health Care Quality Corporation Receives Important Designation from U.S. Department of Health and Human Services

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)..., Nov. 9 "Micro cap and small cap ...ve more broker sponsorship and exposure as a ,buyi...rn in commodity-driven stocks like gold, silver an... The Haft Group, Inc, Manhattan based investor rel...l cap equities market in the US and Canada, and wi...
(Date:11/9/2009)...GHAI, Nov. 9 /PRNewswire-Asia/ -- The pharma and b...lution. The companies are facing significant,pres...ng R&D costs, calls for,lower prices and a gre...with,the financial crisis have made the work of cr...cal companies are being forced to globalize their ...
(Date:11/9/2009)... Product release is a research industry...earch facilities and research safety study data to... Cedar Knolls, NJ (PRWEB) Novembe...y that it has unveiled Pristima™ VM, an inte...acilities that track the use and care of veterinar...
(Date:11/7/2009)...E, Mass., Nov. 7, Research project...red top marks this evening, as Tim Kunisky of Livi...(Jack) Chen of Audubon, PA received the highest ho... Competition in Math, Science & Technology, th.... ,, ( http://www.newscom.com/cgi-bin/prnh/200...
Breaking Biology Technology:Haft Group says Bullish Commodity Market Triggers Small and Micro-cap Upsurge 2Pharma and Biotech Leaders to Converge in Shanghai 2Xybion Unveils Pristima™ VM, an Integrated Enterprise Software Solution for Vivarium and Veterinary Care Management 2Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 2Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 3Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 4Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 5Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 6
...A, Calif., April 10 Dedicating this year,s,Ventur...tute and Burrill &,Company have announced a partne...iences Venture Forum, which will showcase the most...e sciences companies from the U.S. and,around the ...ake place on,May 30, 2008, at the Santa Clara Conv...
...April 10 Intellect Neurosciences,Inc. (OTC Bullet...ned a,Notice of Allowance and completed the grant ...to the Company,s ANTISENILIN(R) antibodies and,pro...ment of Alzheimer,s,disease. Grant of the European...s related to the ANTISENILIN(R) antibodies have be...
...WA, April 10 /PRNewswire-FirstCall/ - Oncothyreon ...at data from preclinical studies,of PX-478, pharma... of,PX-866 will be presented at the Annual Meeting...AACR) in San Diego April 12-16, 2008., Oncothyreo... of PX-478,in patients with advanced metastatic ca...
Other Biology Technology:Larta Institute Partners With Burrill & Company to Present the 14th Annual Life Sciences Venture Forum 2Larta Institute Partners With Burrill & Company to Present the 14th Annual Life Sciences Venture Forum 3Intellect Neurosciences, Inc. Receives Notice of Allowance and Completes Grant Requirements for Pivotal European Patent Related to Passive Immunization of Alzheimer's Disease 2Intellect Neurosciences, Inc. Receives Notice of Allowance and Completes Grant Requirements for Pivotal European Patent Related to Passive Immunization of Alzheimer's Disease 3Intellect Neurosciences, Inc. Receives Notice of Allowance and Completes Grant Requirements for Pivotal European Patent Related to Passive Immunization of Alzheimer's Disease 4Oncothyreon announces data from multiple small molecule programs to be presented at American Association of Cancer Research Annual Meeting 2Oncothyreon announces data from multiple small molecule programs to be presented at American Association of Cancer Research Annual Meeting 3
(Date:11/5/2009)...s (NABT) will recognize Leonard C. Yannielli, prof...ommunity College (NVCC) in Waterbury, Connecticut,...e NABT annual professional development conference .... , The Evolution Education Award is cosponsored...,(AIBS) and Biological Sciences Curriculum Study (...
(Date:11/4/2009)...tant to officially endorse green tea as a cancer p... its protective effects, including results of a ne... a journal of the American Association for Cancer ...ncer. , Vassiliki Papadimitrakopoulo, M.D., pro...ead and Neck Medical Oncology at the University of...
(Date:11/4/2009)...obesity in the United States is reaching epidemic ...ing on daytime and prime time television devoted t...ut the role television plays in obesity, a study i...utrition Education and Behavior examines how food...ntributor to the problem. , Researchers at the U...
Breaking Biology News(10 mins):Biologists, educators recognize excellence in evolution education 2Does green tea prevent cancer? Evidence continues to brew, but questions remain 2TV bombards children with commercials for high-fat and high-sugar foods 2TV bombards children with commercials for high-fat and high-sugar foods 3Omnetics 26apos 3B Multi Contact Nano Connectors Obtain Digital Transmission Rates Over 2 Gb sec 51419 1Omnetics 26apos 3B Multi Contact Nano Connectors Obtain Digital Transmission Rates Over 2 Gb sec 51419 2Select Telecom Adds Surveillance System Installation and Maintenance Services Receives New York State License 51417 1Select Telecom Adds Surveillance System Installation and Maintenance Services Receives New York State License 51417 2Pinnacle Health Solutions Launches New Web Site Making Affordable Health Care and Benefits Easy to Understand 51415 1Pinnacle Health Solutions Launches New Web Site Making Affordable Health Care and Benefits Easy to Understand 51415 2
...2; For the third time in 14 months, the Empire Sta...lege of Medicine of Yeshiva University funding for...7 million, will help create technologies for treat...sease, as well as obesity and hepatitis. , In app...g federal funding for stem cell research, Governor...
...pport, renewable energy technologies like wind and...d,s electricity by 2050, according to findings fro...hange: Global Risks, Challenges & Decisions." Howe...are is likely to hover below 15 percent. , This ...ter Lund of the Helsinki University of Technology,...
...ratures may provide clues about whether or not hum...ade Winterhalter landed an $860,000 grant from the... that fuses global warming models with a biologica... the striped ground cricket, also known as the All... study could provide insights into the impact of g...
Other Biology News:Empire State Stem Cell Board awards $12.7 million to Albert Einstein College of Medicine 2Empire State Stem Cell Board awards $12.7 million to Albert Einstein College of Medicine 3New renewables to power 40 per cent of global electricity demand by 2050 2Crickets may predict human survivability during global warming 2
Dengue Virus IgG ELISA Kit, Single from Bio-Quant Inc.
Brucella IgG ELISA Kit, Single from Bio-Quant Inc.
Agarose-LE from GE Healthcare, formerly Amersham Biosciences
Methadone ELISA Kit, Single from Bio-Quant Inc.
Biology Products: